Mexico seizes almost 47,000 faulty HIV test kits

February 1, 2017

The latest in a series of medicine scandals is hitting Mexico with the government's seizure of almost 47,000 Chinese-made HIV testing kits that it says could give false negative results.

The government's medical oversight agency says the kits "could give false negatives and put at risk the lives of patients who didn't receive ."

The agency said late Monday the kits were seized at a government medical warehouse in the Gulf coast state of Veracruz.

That's the same state where officials have accused a previous administration of supplying fake medicines for state-run hospitals. The current Veracruz governor says an inert substance was administered to children instead of a cancer drug.

Explore further: Brazil's Health Ministry delays providing dengue test kits

Related Stories

Brazil's Health Ministry delays providing dengue test kits

February 12, 2016
Brazilian laboratories say delays in providing kits to test for mosquito-borne dengue have forced them to store patient blood samples until the kits are delivered.

CDC sends Florida 950 kits to test for Zika virus antibodies

February 9, 2016
Federal health officials have sent the state of Florida an additional 950 kits to test for viral antibodies in people who have shown Zika symptoms after traveling to affected countries.

Narcan project has stopped nine opioid overdoses; seeks additional naloxone kits

September 23, 2016
A University of Alabama at Birmingham crowdfunded study to provide naloxone kits to family and friends of at-risk opioid users has distributed over 100 kits and has seen nine overdose reversals since it began in Nov. 2015. ...

China launches crackdown on drug industry

July 17, 2013
(AP)—China announced a crackdown Wednesday on misconduct in its drug market, stepping up pressure on the problem-prone industry while it pursues a bribery investigation of GlaxoSmithKline.

US regulators recall 10-minute Ebola test

April 23, 2015
US regulators have issued an international recall for a 10-minute Ebola blood test made by a California-based company, saying it has not been proven to work and could put lives at risk.

Recommended for you

Paris spotlight on latest in AIDS science

July 21, 2017
Some 6,000 HIV experts gather in Paris from Sunday to report advances in AIDS science as fading hopes of finding a cure push research into new fields.

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

Heart toxin reveals new insights into HIV-1 integration in T cell genome

July 20, 2017
Human immunodeficiency virus (HIV)-1 may have evolved to integrate its genetic material into certain immune-cell-activating genes in humans, according to new research published in PLOS Pathogens.

Scientists capture first high-resolution image of key HIV protein transitional state

July 13, 2017
A new, three-dimensional snapshot of HIV demonstrates the radical structural transformations that enable the virus to recognize and infect host cells, according to a new study led by scientists at The Scripps Research Institute ...

Barrier to autoimmune disease may open door to HIV, study suggests

July 11, 2017
Researchers from the University of Colorado School of Medicine have discovered that a process that protects the body from autoimmune disease also prevents the immune system from generating antibodies that can neutralize the ...

Team tests best delivery mode for potential HIV vaccine

June 20, 2017
For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.